Filing Details

Accession Number:
0001209191-21-005470
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-26 17:24:07
Reporting Period:
2020-12-16
Accepted Time:
2021-01-26 17:24:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850261 Sorrento Therapeutics Inc. SRNE Biological Products, (No Disgnostic Substances) (2836) 330344842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1717947 Dorman Followwill C/O Sorrento Therapeutics, Inc.
4955 Directors Place
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-11 1,000 $0.00 3,130 No 5 W Direct
Common Stock Disposition 2020-12-16 1,000 $7.14 2,130 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 W Direct
No 4 S Direct